Newsroom

Recent News Releases

Takeda selected for the eighth consecutive year for Dow Jones Sustainability Asia Pacific Index
Takeda and Noile-Immune Biotech Collaborate to Advance Next Generation CAR-T Cell Therapy Effective for Solid Tumors
Takeda Submits a New Drug Application for Vedolizumab for the Treatment of Moderately to Severely Ulcerative Colitis in Japan
Takeda and Molecular Templates Announce Multi-Target Research and Licensing Collaboration to Develop Next-Generation Oncology Therapies 
Takeda and Cardurion Pharmaceuticals Launch Cardiovascular Development Partnership

SEE ALL NEWS AND RELEASES >

In the News

In life, there are great opportunities as well as great challenges and risks. With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.
LEARN MORE

Featured Topics

Strengthening our global production network in Oranienburg
LEARN MORE

#InTheirShoes: What it’s like to be an IBD patient – how we’ve approached it
LEARN MORE

Takeda Recognized for Commitment to Quality
LEARN MORE

Inflammatory Bowel Disease (IBD) Patient Engagement in R&D
LEARN MORE

FOR MORE TOPICS>

Executive Leadership

ceo1600x900

Meet our Executive Leadership Team led by our President and CEO, Christophe Weber LEARN MORE

For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.

Copyright 1995-2017 Takeda Pharmaceutical Company Limited. All rights reserved.
 

Internal Disclaimer Header

Internal Disclaimer Body

CANCEL